Lipid metabolizing enzyme ACSM2B is a potential negative regulator of liver cancer progression
Zhengfeng Xu,
Hongwei Yu,
Xingchu Meng,
Ze Yu
Affiliations
Zhengfeng Xu
Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilong jiang Province, China; The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China
Hongwei Yu
Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China
Xingchu Meng
Corresponding authors.No.37 Yiyuan Street, Nangang District, Harbin, Heilong jiang Province, 150001, China.; Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilong jiang Province, China
Ze Yu
Corresponding authors. No.739 Dingshen Road, Lincheng New District, Zhoushan, Zhejiang Province, 316021, China.; Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China; The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China